Skip to main content
. 2019 May 9;85(7):1528–1537. doi: 10.1111/bcp.13934

Figure 2.

Figure 2

Change in rivaroxaban exposure in healthy volunteers during treatment with ciclosporin (CsA, squares) and ciclosporin in combination with fluconazole (CsA + FLC, triangles). Horizontal lines indicate geometric means. P values refer to the difference between the mean log‐transformed ratio and a hypothetical ratio of 1